It’s not easy being a CEO on the hot seat at a conference when your company’s stock is down nearly 30% over the last 12 months. Allergan (NYSE: AGN) CEO Brent Saunders experienced that first-hand at the Goldman Sachs Healthcare CEOs Unscripted event on Thursday. Here’s what Saunders had to say on several key topics.
Image source: Allergan.